Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$2.05 -0.04 (-1.91%)
2/9/2010 4:00 PM

Novavax, Inc. (NVAX)

CAPS Rating:
*

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating NVAX

Add Stock to Watchlist

What the Community Thinks

Total Members

201 Outperforms
100 Underperforms
 

All-Stars

64 Outperforms
56 Underperforms
 

Wall Street

3 Outperforms
1 Underperforms
 

Members bullish on NVAX are also bullish on:

Members bearish on NVAX are also bearish on:

Ticker Tags

Healthcare (711), Rule Breakers Universe (125), Bird Flu (7), Aggressive Growth (860), Biotechnology (220), Growth (1902), Defensive (1457), Micro Cap (4701)
Suggest a tag

Novavax, Inc. At A Glance

Current Price: $2.05
Last Trade Time: 2/9/2010 4:00 PM
Open: $2.09
Previous Close: $2.09
Daily Range: $1.99 - $2.14
52-Week Range: $0.52 - $7.79
Volume: 1,083,748
Market Cap: $191.65M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

NVAX VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Novavax, Inc. (NVAX)

Avatar JPG101 (91.96) Submitted: 7/11/09 8:24 PM

The fear of a significant pandemic seem, for the first time in a very long time, justified. Pandemic H1N1 seems to be a significant possibility.
This small company just obtained 2 partnerships (in Spain and India) with credible companies. The Spanish gouvernment favors Novavax tech. They seem to ...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Novavax, Inc. (NVAX)

Avatar VoodooEconomist (83.41) Submitted: 7/02/09 3:14 PM

A swine flue play.... think swine flue is played out. The company has nothing in the way of sales and isn't profitable now. Even if it gets a swine flu bump, it's short term. Selling at 400x sales according to published ratios.

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 46 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (NVAX)

Avatar quinpeung (73.34) Submitted: 2/05/10 2:20 PM : Underperform Start Price: $2.05 NVAX Score: 1.93

Just a matter of time until this one returns to pre-scare values.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVAX)

Avatar EclecticRecluse (74.33) Submitted: 2/01/10 3:04 AM : Outperform Start Price: $2.19 NVAX Score: -5.53

Technical Bounce Likely

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVAX)

Avatar JLuz (96.88) Submitted: 9/28/09 2:16 PM : Underperform Start Price: $4.37 NVAX Score: 53.98

can't believe this is still going up. Re-entering thumbs down. Swine flu... are you kidding me?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVAX)

Avatar bestdamstockpkr (72.14) Submitted: 9/02/09 12:18 PM : Outperform Start Price: $6.00 NVAX Score: -73.47

Not a stock I would normally pick. That being said, I think the analyst were to quick to downgrade this morning due to their ability to get the vaccines out quickly. I know I am going out on a limb here but I think it will very soon see new highs for the year.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (NVAX)

Avatar T5enterprise (71.51) Submitted: 9/01/09 4:40 PM : Outperform Start Price: $6.15 NVAX Score: -74.65

H1N1

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 46 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackGlobalHunte 45.07 12/03/09 Outperform NS $3.55-42.25%-3.88%-38.37
TrackPiperJaff 85.79 12/02/09 Outperform NS $3.14-34.71%-3.34%-31.38
TrackMerriman < 20 11/05/09 Outperform NS $3.92-47.70%+1.48%-49.18
TrackJimCramer < 20 03/01/06 Underperform 3W $5.69-63.97%-11.10%+52.87

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 906ms